The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; none of the 99 sources its claims cite is checked for support yet.
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Open accessAbstract
Background/Aims: The diagnostic criteria for polycystic ovary syndrome (PCOS) in adolescence are controversial, primarily because the diagnostic pathological features used in adult women may be normal pubertal physiological events. Hence, international pediatric and adolescent specialty societies have defined criteria that have sufficient evidence to be used for the diagnosis of PCOS in adolescents. Methods: The literature has been reviewed and evidence graded to address a series of questions regarding the diagnosis of PCOS during adolescence including the following: clinical and biochemical evidence of hyperandrogenism, criteria for oligo-anovulation and polycystic ovary morphology, diagnostic criteria to exclude other causes of hyperandrogenism and amenorrhea, role of insulin resistance, and intervention. Results and Conclusion: Features of PCOS overlap normal pubertal development. Hence, caution should be taken before diagnosing PCOS without longitudinal evaluation. However, treatment may be indicated even in the absence of a definitive diagnosis. While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
53 Not checked yet · 18 Own interpretation · 6 No basis given · 2 Own method
In the paper
“The diagnostic criteria for PCOS in adolescence are controversial, primarily because the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
What the sources say
- Not checked yetcites [18] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“With the exception of one published recommendation, none of the current definitions of PCOS in adolescent or adult women include insulin resistance/hyperinsulinemia as a diagnostic criterion [1, 10-12, 18, 19, 112]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“It is important to realize that about half of otherwise asymptomatic mild hirsutism is not associated with hyperandrogenemia [22,24]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, mild or focal hirsutism may be a sign of hyperandrogenemia in young women when associated with other evidence of PCOS, i.e., menstrual irregularity [29][30][31][32]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [29][30][31][32]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Insulin resistance and hyperinsulinemia are intrinsic to PCOS in adults and adolescents, lean or obese.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The severity of hirsutism does not correlate well with circulating androgen concentrations [26]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [26] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Hyperinsulinemia is believed to exacerbate the hyperandrogenism and the reproductive and metabolic manifestations of PCOS in adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“All adult PCOS criteria consider hirsutism as evidence of clinical hyperandrogenism.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [10][11][12]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Features of PCOS overlap normal pubertal development.”
- Also stated in: § Introduction · hedged
“the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
What the sources say
- Not checked yetcites [18] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · hedged
- Probably not a substantial claim. 12
- It may state two separate claims as one. 21
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, insulin resistance and/ or hyperinsulinemia should not be used to diagnose PCOS among adolescent girls.”
- Also stated in: § Recommendations · plain
“Although prevalent among adolescents at risk for PCOS, insulin resistance and hyperinsulinemia should not be utilized as diagnostic criteria (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Also stated in: § Recommendations · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Upper lip scores of 3-4 were found in <3% of Black and White US adolescents, though scores of 1-2 rose in prevalence from 7.3% at <2 years after menarche to 28.2% at >2 years after menarche [40,41]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Even though hirsutism is common among women with hyperandrogenism, the latter can occur in the absence of cutaneous manifestations [2,3]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Biochemical evidence of hyperandrogenism, as indicated by persistent elevation of serum total and/or free testosterone levels and determined in a reliable reference laboratory, provides the clearest support for the presence of hyperandrogenism in an adolescent girl with symptoms of PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“PCOM, variously defined, has been reported with a prevalence of 30-40% (range between 26 and 54%) and has been described in healthy girls [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“weight loss, treatment with metformin, or treatment with rosiglitazone were associated with improved insulin sensitivity and attenuation of hyperandrogenemia in some studies [133][134][135][136][137]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [133][134][135][136][137]
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Further, a multifollicular pattern, which is defined by the presence of large follicles distributed throughout the ovary, does not have a relationship with hyperandrogenism, is more common in adolescents, and should not be considered a pathological finding (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a population-based study from Australia of adolescents considered to have PCOS in which increased free testosterone concentration was the factor most predictive of insulin resistance, while menstrual irregularities and polycystic ovaries were not associated with insulin resistance [127]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [127] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Menstrual irregularity is common among adolescents and is generally the result of anovulatory cycles.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although morning 17-OHP concentrations (>200 ng/dl) have been reported as being more common in women with CAH (87%), over 20% of women with PCOS had elevated morning 17-OHP values [110]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [110] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Regular cycles (21-45 days) are established by the third year after menarche in approximately 95% of girls, but cycles can remain irregular until the fifth year.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [64][65][66][67]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Accordingly, the persistence of oligomenorrhea (menstrual cycles longer than 45 days), secondary amenorrhea (absence of cycles for more than 3 months), or primary amenorrhea in girls with complete pubertal development and adult stature suggests the coexistence of androgen excess [71,78]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While comedonal acne is common in adolescent girls, moderate or severe comedonal acne (i.e., 10 or more facial lesions) in early puberty or moderate inflammatory acne through the perimenarcheal years is uncommon (<5% prevalence) [42,43]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moderate to severe hirsutism constitutes clinical evidence of hyperandrogenism (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The reported prevalence for NCAH is 1 in 1,000 with an increased prevalence in specific ethnic groups [99]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [99] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Legro et al. [69] found that over 90% of adolescent females have 10 or more menstrual cycles per year (average menstrual interval 36.5 days) 3 years after menarche.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [69] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Follow-up of a different group of unselected healthy adolescents for 12 years showed tracking of androgen levels into adulthood; higher levels in adolescence were associated with lower fertility, suggesting evolving PCOS [59]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [59] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Follicle counts should not be utilized to define PCOM in adolescents (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No compelling criteria to define PCOM have been established for adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Rests on an assumption: No compelling criteria to define polycystic ovary morphology have been established for adolescents.
In the paper
“In a study of unselected schoolgirls with oligomenorrhea, 4% had hirsutism and 57% had elevated testosterone levels [58]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [58] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Until further research establishes definitive criteria, an ovarian volume >12.0 cm 3 (by formula for a prolate ellipsoid) can be considered en-”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lack of onset of menses by age 15 years or by more than 2-3 years after thelarche regardless of chronologic age is statistically uncommon and warrants evaluation and consideration of diagnoses such as PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For these reasons, testosterone concentrations should be considered elevated when they are persistently greater than the adult female normative values according to assays performed by specialty laboratories with welldefined reference intervals.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A single androgen level >2 SD above the mean for the specific assay should not be considered to be evidence of hyperandrogenism in an otherwise asymptomatic adolescent girl (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Hence, PCOM is an inconsistent finding and does not invariably predict the development of PCOS [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Gambineri et al. [61] defined hyperandrogenism during the follicular phase as total testosterone concentrations >42 ng/dl using a LC-MS/MS assay.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [61] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“These trials have also shown improvements related to hirsutism, ovulation, quality of life, sleep, lipid profile, adipocytokine levels, and insulin resistance [148-160]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A diagnosis of PCOS can impact an adolescent's quality of life; this diagnosis can create early and unwarranted anxiety about future fertility for the young women and her family.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“PCOS is a common heterogeneous phenotype with features overlapping some features characteristic of normal pubertal development.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Summary
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Longer duration trials (12 months or more) are very limited and are either open-labelled trials or lack placebocontrolled arms [133, 135, 161-163]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
No consensus exists on the clinical criteria for diagnosing androgen excess in adolescence.
“No consensus exists on the clinical criteria to reach the diagnosis of androgen excess in adolescence.”
The paper relies on this without support.
The definition of persistent oligomenorrhea is uncertain.
“However, the definition of 'persistent oligomenorrhea' is uncertain.”
The paper relies on this without support.
Detailed data are not available regarding the accuracy of predicting ongoing hyperandrogenic anovulation from a single elevated testosterone level.
“However, detailed data are not available regarding the accuracy of the prediction of ongoing hyperandrogenic anovulation from a single elevated testosterone level.”
The paper relies on this without support.
No data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of polycystic ovary syndrome in adulthood.
“Further, no data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of PCOS in adulthood.”
The paper relies on this without support.
No compelling criteria to define polycystic ovary morphology have been established for adolescents.
“No compelling criteria to define PCOM have been established for adolescents.”
The paper relies on this without support.
Available data are inconsistent regarding the usefulness of anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome among adolescent girls.
“Available data are inconsistent regarding the usefulness of AMH in the diagnosis of PCOS among adolescent girls [92][93][94][95][96]”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Often each clinical symptom and comorbidity is treated separately, which can delay or obscure a diagnosis of PCOS and limit follow up care [3, 22, 23].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“These similarities between normal pubertal development and the clinical features associated with PCOS confound the diagnosis in adolescent girls (Table 1) [125–127].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
In the citing paper
“However, delineating appropriate diagnostic criteria for PCOS among adolescent girls has been problematic because irregular menses, cystic acne, mild hyperandrogenism, and multifollicular ovarian morphology occur during normal pubertal maturation.”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationDabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Research works printed but not linked: 110
- 10.1016/j.fertnstert.2011.09.024 · DOI · Paper page
- 10.1210/jc.2005-1457 · DOI · Paper page
- 10.1038/ijo.2008.61 · DOI
- 10.1210/me.13.6.946 · DOI · Paper page
- 10.1038/nrendo.2014.58 · DOI · Paper page
- 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
- 10.1016/j.fertnstert.2008.06.035 · DOI · Paper page
- 10.1111/j.1365-2265.2007.02764.x · DOI · Paper page
- 10.1093/humrep/der418 · DOI · Paper page
- 10.1016/j.ajog.2010.03.008 · DOI · Paper page
- 10.1210/jc.2013-2350 · DOI · Paper page
- 10.1210/jc.2006-0178 · DOI · Paper page
- 10.1136/qhc.12.1.18 · DOI · Paper page
- 10.1210/er.21.4.363 · DOI
- 10.1210/jc.2007-2437 · DOI
- 10.1590/S0004-27302011000800013 · DOI · Paper page
- 10.1093/humupd/dmp024 · DOI · Paper page
- 10.3109/09513590.2013.797399 · DOI
- 10.4161/derm.1.2.8354 · DOI · Paper page
- 10.1016/j.jpag.2009.03.007 · DOI
- 10.1016/j.ajog.2004.06.064 · DOI
- 10.1016/j.fertnstert.2009.02.056 · DOI
- 10.1111/j.1524-4725.2012.02462.x · DOI
- 10.1001/archderm.135.6.656 · DOI
- 10.1016/j.fertnstert.2011.06.040 · DOI
- 10.1210/jc.2004-2301 · DOI
- 10.1016/j.bpobgyn.2004.05.007 · DOI
- 10.1136/jfprhc-2011-100175 · DOI
- 10.1067/mpd.2001.109790 · DOI
- 10.1210/jcem-21-11-1440 · DOI
- 10.1016/S0022-3476(97)70307-X · DOI
- 10.1542/peds.2013-0490B · DOI
- 10.1210/jc.2010-1123 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.056 · DOI
- 10.1210/jc.84.10.3666 · DOI · Paper page
- 10.1210/jc.2013-3399 · DOI
- 10.1016/S0022-3476(83)80678-7 · DOI
- 10.1210/jcem.85.4.6543 · DOI
- 10.1210/jc.2008-2771 · DOI
- 10.1210/jc.2013-1770 · DOI
- 10.1210/jcem-45-5-1039 · DOI
- 10.1093/humrep/14.9.2223 · DOI
- 10.1210/jcem-71-4-970 · DOI
- 10.1203/00006450-199512000-00024 · DOI
- 10.1210/jc.2012-3537 · DOI
- 10.1677/joe.0.0970213 · DOI
- 10.1016/S1043-2760(98)00020-4 · DOI · Paper page
- 10.1210/jc.2007-1846 · DOI · Paper page
- 10.1093/humrep/deh079 · DOI · Paper page
- 10.1097/00006254-196608000-00009 · DOI
- 10.1136/adc.44.235.291 · DOI · Paper page
- 10.1542/peds.2006-2481 · DOI · Paper page
- 10.1016/S0197-0070(86)80014-6 · DOI
- 10.1053/beem.2002.0203 · DOI · Paper page
- 10.1093/humrep/der102 · DOI
- 10.1016/S0140-6736(85)92552-8 · DOI
- 10.1016/j.fertnstert.2010.06.015 · DOI · Paper page
- 10.1515/jpem-2012-0014 · DOI
- 10.1210/jc.2014-3336 · DOI
- 10.1371/journal.pone.0071465 · DOI
- 10.1016/j.jpag.2013.11.007 · DOI · Paper page
- 10.1007/s00330-009-1643-8 · DOI
- 10.1016/j.fertnstert.2009.11.002 · DOI
- 10.1093/humrep/der223 · DOI
- 10.1093/humupd/dmt062 · DOI
- 10.1515/jpem-2012-0013 · DOI
- 10.1016/j.ejogrb.2014.06.018 · DOI
- 10.1016/j.steroids.2011.12.009 · DOI
- 10.1155/2010/625105 · DOI
- 10.1111/j.1365-2362.2011.02550.x · DOI
- 10.1080/09513590701297708 · DOI
- 10.4274/Jcrpe.835 · DOI
- 10.1210/jc.86.1.207 · DOI · Paper page
- 10.1016/j.fertnstert.2006.04.015 · DOI · Paper page
- 10.1067/mpd.2001.109603 · DOI · Paper page
- 10.1210/jcem.80.10.7559882 · DOI
- 10.1210/jcem.84.12.6341 · DOI · Paper page
- 10.1016/j.metabol.2005.11.003 · DOI · Paper page
- 10.1210/jc.2005-1666 · DOI
- 10.1210/jc.2008-1198 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.046 · DOI
- 10.1016/j.jpeds.2012.11.019 · DOI
- 10.1016/j.fertnstert.2011.03.001 · DOI
- 10.1210/jc.87.3.1017 · DOI · Paper page
- 10.1080/09513590802630146 · DOI
- 10.1210/jcem-62-5-904 · DOI
- 10.1210/edrv.18.6.0318 · DOI
- 10.1046/j.1365-2265.1999.00770.x · DOI
- 10.1210/jc.87.4.1555 · DOI · Paper page
- 10.1016/S1054-139X(01)00202-6 · DOI
- 10.1093/humrep/del185 · DOI
- 10.1210/jc.2010-2547 · DOI
- 10.1210/jc.2005-0438 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1210/jc.2003-031848 · DOI
- 10.1136/adc.2004.053959 · DOI
- 10.1210/jc.2006-2002 · DOI
- 10.1515/JPEM.2005.18.8.761 · DOI · Paper page
- 10.1001/archpedi.160.3.241 · DOI · Paper page
- 10.1210/jc.2008-0461 · DOI · Paper page
- 10.1016/j.jpag.2013.09.011 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1016/j.fertnstert.2009.08.006 · DOI · Paper page
- 10.1016/j.jpag.2014.01.004 · DOI
- 10.1111/cen.12028 · DOI
- 10.1210/jc.2003-031281 · DOI
- 10.1210/jc.2011-1609 · DOI · Paper page
- 10.1080/713603060 · DOI · Paper page
- 10.1210/jc.2013-1041 · DOI · Paper page
- 10.1016/S0015-0282(02)02993-X · DOI · Paper page
Cited by
Sorted by citations
Variations in the pattern of pubertal changes in boys
Marshall, W. A., & Tanner, J. M. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.13 · Cited by 5,147
Tanner, J. M., & Whitehouse, R. H. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.3.170 · Cited by 3,137
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Self-citationRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Self-citationTeede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.004 · Cited by 1,325
Self-citationHampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationBoehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Self-citationAnti-müllerian hormone and ovarian reserve: Update on assessing ovarian function
Moolhuijsen, L. M. E., & Visser, J. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa513 · Cited by 584
Stress response and the adolescent transition: performance versus peer rejection stressors
Stroud, L. R., Foster, E., Papandonatos, G. D., Handwerger, K., Granger, D. A., Kivlighan, K. T., & Niaura, R. (2009) · Development and Psychopathology · doi:10.1017/s0954579409000042 · Cited by 610
Pubertal development and regulation
Abreu, A. P., & Kaiser, U. B. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00418-0 · Cited by 611
Breast milk, a source of beneficial microbes and associated benefits for infant health
Lyons, K. E., Ryan, C. A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2020) · Nutrients · doi:10.3390/nu12041039 · Cited by 613
Azziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Genetic, hormonal and metabolic aspects of PCOS: an update
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Self-citationDay, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459
Sex differences in the developing brain: insights from multimodal neuroimaging
Kaczkurkin, A. N., Raznahan, A., & Satterthwaite, T. D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0111-z · Cited by 403
Gibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2963 · Cited by 428
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles
Bull, J. R., Rowland, S. P., Scherwitzl, E. B., Scherwitzl, R., Danielsson, K. G., & Harper, J. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0152-7 · Cited by 404
Insulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Self-citationZhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145003 · Cited by 353
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Self-citationPubertal assessment method and baseline characteristics in a mixed longitudinal study of girls
Biro, F. M., Galvez, M. P., Greenspan, L. C., Succop, P. A., Vangeepuram, N., Pinney, S. M., Teitelbaum, S., Windham, G. C., Kushi, L. H., & Wolff, M. S. (2010) · Pediatrics · doi:10.1542/peds.2009-3079 · Cited by 348
Current Guidelines for Diagnosing PCOS
Christ, J. P., & Cedars, M. I. (2023) · Diagnostics · doi:10.3390/diagnostics13061113 · Cited by 340
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Roles of oxidative stress in polycystic ovary syndrome and cancers
Zuo, T., Zhu, M., & Xu, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8589318 · Cited by 319
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Adolescence: what do transmission, transition and translation have to do with it?
Casey, B. J., Duhoux, S., & Cohen, M. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.033 · Cited by 297
Caprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283
Meta-analysis of genome-wide association data identifies two loci influencing age at menarche
Perry, J. R. B., Stolk, L., Franceschini, N., Lunetta, K. L., Zhai, G., McArdle, P. F., Smith, A. V., Aspelund, T., Bandinelli, S., Boerwinkle, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.386 · Cited by 294
Paediatric and adult-onset male hypogonadism
Salonia, A., Rastrelli, G., Hackett, G., Seminara, S. B., Huhtaniemi, I. T., Rey, R. A., Hellstrom, W. J. G., Palmert, M. R., Corona, G., Dohle, G. R., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0087-y · Cited by 286
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Early neglect is associated with alterations in white matter integrity and cognitive functioning
Hanson, J. L., Adluru, N., Chung, M. K., Alexander, A. L., Davidson, R. J., & Pollak, S. D. (2013) · Child Development · doi:10.1111/cdev.12069 · Cited by 276
11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267
Leyendecker, G., Bilgicyildirim, A., Inacker, M., Stalf, T., Huppert, P., Mall, G., Böttcher, B., & Wildt, L. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3437-8 · Cited by 261
Tanofsky-Kraff, M., Cohen, M. L., Yanovski, S. Z., Cox, C., Theim, K. R., Keil, M., Reynolds, J. C., & Yanovski, J. A. (2006) · Pediatrics · doi:10.1542/peds.2005-1329 · Cited by 258
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis
Brutocao, C., Zaiem, F., Alsawas, M., Morrow, A. S., Murad, M. H., & Javed, A. (2018) · Endocrine · doi:10.1007/s12020-018-1692-3 · Cited by 251
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
The Effects of a Low-Carbohydrate, Ketogenic Diet on the Polycystic Ovary Syndrome: A Pilot Study
Mavropoulos, J. C., Yancy, W. S., Hepburn, J., & Westman, E. C. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-35 · Cited by 226
Dokras, A., Saini, S., Gibson-Helm, M., Schulkin, J., Cooney, L., & Teede, H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.04.011 · Cited by 218
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
Binge eating in overweight treatment-seeking adolescents
Glasofer, D. R., Tanofsky-Kraff, M., Eddy, K. T., Yanovski, S. Z., Theim, K. R., Mirch, M. C., Ghorbani, S., Ranzenhofer, L. M., Haaga, D., & Yanovski, J. A. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsl012 · Cited by 212
O’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215
Moore, M., Kirchner, H. L., Drotar, D., Johnson, N., Rosen, C., & Redline, S. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.07.020 · Cited by 211
Sex, microbes, and polycystic ovary syndrome
Thackray, V. G. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.11.001 · Cited by 203
Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz196 · Cited by 211
Gunnar, M. R., DePasquale, C. E., Reid, B. M., Donzella, B., & Miller, B. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909699116 · Cited by 207
The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome
Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146509 · Cited by 205
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206
A systematic literature review of sex differences in childhood language and brain development
Etchell, A., Adhikari, A., Weinberg, L. S., Choo, A. L., Garnett, E. O., Chow, H. M., & Chang, S.-E. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.04.011 · Cited by 193
Emerging Adulthood, a Pre-adult Life-History Stage
Hochberg, Z., & Konner, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00918 · Cited by 204
Dunaif, A., & Graf, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113864 · Cited by 204
Liu, J., Wu, Q., Hao, Y., Jiao, M., Wang, X., Jiang, S., & Han, L. (2021) · Human Reproduction · doi:10.1093/humrep/deaa371 · Cited by 203
Age of menarche in a longitudinal US cohort
Biro, F. M., Pajak, A., Wolff, M. S., Pinney, S. M., Windham, G. C., Galvez, M. P., Greenspan, L. C., Kushi, L. H., & Teitelbaum, S. L. (2018) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2018.05.002 · Cited by 200
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200
The management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191
Polycystic ovary syndrome throughout a woman’s life
Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180
Peper, J. S., Schnack, H. G., Brouwer, R. M., Van Baal, G. C. M., Pjetri, E., Székely, E., van Leeuwen, M., van den Berg, S. M., Collins, D. L., Evans, A. C., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20660 · Cited by 177
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Age at Menarche and Menstrual Cycle Pattern among School Adolescent Girls in Central India
Dambhare, D. G., Wagh, S. V., & Dudhe, J. Y. (2011) · Global Journal of Health Science · doi:10.5539/gjhs.v4n1p105 · Cited by 181
Does puberty mark a transition in sensitive periods for plasticity in the associative neocortex?
Piekarski, D. J., Johnson, C. M., Boivin, J. R., Thomas, A. W., Lin, W. C., Delevich, K., M. Galarce, E., & Wilbrecht, L. (2017) · Brain Research · doi:10.1016/j.brainres.2016.08.042 · Cited by 175
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
The relationship between puberty and social emotion processing
Goddings, A., Burnett Heyes, S., Bird, G., Viner, R. M., & Blakemore, S. (2012) · Developmental Science · doi:10.1111/j.1467-7687.2012.01174.x · Cited by 169
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess
New, M. I., & Wilson, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12790 · Cited by 164
The perceived onset of dieting and loss of control eating behaviors in overweight children
Tanofsky-Kraff, M., Faden, D., Yanovski, S. Z., Wilfley, D. E., & Yanovski, J. A. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20158 · Cited by 156
Kite, C., Lahart, I. M., Afzal, I., Broom, D. R., Randeva, H., Kyrou, I., & Brown, J. E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0962-3 · Cited by 155
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154
Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
Recent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142
Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
Measures of health-related quality of life in PCOS women: a systematic review
Behboodi Moghadam, Z., Fereidooni, B., Saffari, M., & Montazeri, A. (2018) · International Journal of Women's Health · doi:10.2147/ijwh.s165794 · Cited by 129
Zhao, X., Jiang, Y., Xi, H., Chen, L., & Feng, X. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1081-2036 · Cited by 124
Rossi, B., Sukalich, S., Droz, J., Griffin, A., Cook, S., Blumkin, A., Guzick, D. S., & Hoeger, K. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1198 · Cited by 120
Kazemi, M., McBreairty, L. E., Chizen, D. R., Pierson, R. A., Chilibeck, P. D., & Zello, G. A. (2018) · Nutrients · doi:10.3390/nu10101387 · Cited by 118
Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort
Maghnie, M., Ranke, M. B., Geffner, M. E., Vlachopapadopoulou, E., Ibáñez, L., Carlsson, M., Cutfield, W., Rooman, R., Gomez, R., Wajnrajch, M. P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac517 · Cited by 120
Self-citationCooney, L. G., Milman, L. W., Hantsoo, L., Kornfield, S., Sammel, M. D., Allison, K. C., Epperson, C. N., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.028 · Cited by 117
McCartney, C. R., Prendergast, K. A., Blank, S. K., Helm, K. D., Chhabra, S., & Marshall, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1252 · Cited by 116
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115
Coping with social stress: Implications for psychopathology in young adolescent girls
Sontag, L. M., Graber, J. A., Brooks-Gunn, J., & Warren, M. P. (2008) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-008-9239-3 · Cited by 112
Tasali, E., Van Cauter, E., Hoffman, L., & Ehrmann, D. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0925 · Cited by 111
Franks, S., & Hardy, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00452 · Cited by 109
Neural correlates of reversal learning in severe mood dysregulation and pediatric bipolar disorder
Adleman, N. E., Kayser, R., Dickstein, D., Blair, R. J. R., Pine, D., & Leibenluft, E. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.07.011 · Cited by 106
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103
The interplay between androgens and the immune response in polycystic ovary syndrome
Shabbir, S., Khurram, E., Moorthi, V. S., Eissa, Y. T. H., Kamal, M. A., & Butler, A. E. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04116-4 · Cited by 108
Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients
Van der Kamp, H. J. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.2.139 · Cited by 104
Ethnic and sex differences in skeletal maturation among the Birth to Twenty cohort in South Africa
Cole, T. J., Rousham, E. K., Hawley, N. L., Cameron, N., Norris, S. A., & Pettifor, J. M. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2014-306399 · Cited by 100
Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04562-1 · Cited by 96
Metadata
- Authors
- Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., Tfayli, H., Arslanian, S., Dabadghao, P., Garcia Rudaz, C., & Lee, P. A.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- Morgan Stanley Children's Hospital (US)
- University of Chicago (US)
- Nationwide Children's Hospital (US)
- Hospital Sant Joan de Déu Barcelona (ES)
- National Center For Child Health and Development (JP)
- Baylor College of Medicine (US)
- American University of Beirut Medical Center (LB)
- University of Pittsburgh (US)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Pennsylvania State University (US)
- ORCID
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 6
- Pages
- 376-389
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2053105417
- Cited by
- 3,113
- References
- 67
- Citations by year
- 2026: 17 · 2025: 119 · 2024: 197 · 2023: 328 · 2022: 357 · 2021: 237 · 2020: 231 · 2019: 276 · 2018: 244 · 2017: 223 · 2016: 206 · 2015: 187
- FWCI
- 43.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- National Center for Research Resources (M01RR010732)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, adolescents, diagnostic criteria, hyperandrogenism, oligoanovulation, polycystic ovary morphology, insulin resistance, hyperinsulinemia, obesity, amenorrhea, longitudinal assessment
- MeSH terms
- Adolescent, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Puberty, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
